Characterisation and differential expression of two very closely related G-protein-coupled receptors, GPR139 and GPR142, in mouse tissue and during mouse development
about
The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site.Discovery and pharmacological effects of a novel GPR142 antagonist.High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139Identifying ligands at orphan GPCRs: current status using structure-based approaches.Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139.Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy Studies.Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139.A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development.The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRW.Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP(+) and Rotenone Toxicity.An association and haplotype analysis of porcine maternal infanticide: a model for human puerperal psychosis?Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes.Differential role of GPR142 in tryptophan-mediated enhancement of insulin secretion in obese and lean mice.Re-evaluation of Adrenocorticotropic Hormone and Melanocyte Stimulating Hormone Activation of GPR139 in Vitro.Systemic and Intra-Habenular Activation of the Orphan G Protein-Coupled Receptor GPR139 Decreases Compulsive-Like Alcohol Drinking and Hyperalgesia in Alcohol-Dependent Rats.
P2860
Q33683166-D8B2F3EC-E884-4633-8449-973D014DC0CEQ36180895-B03E813D-71FE-4AF1-9028-32BEBE9791B5Q36287768-2BAAE9AD-1111-4740-93E9-90C1BC13EAD1Q38720041-D6587E30-0894-49C6-B539-2FBA4E97A5C2Q38796809-08C9E87A-69A3-411D-8A35-048F16F89F3AQ39778101-8742C8EB-ADA3-408B-97AD-BDC49ECDE39BQ39792717-4F3249B1-4BD9-4293-AF4D-C1CC510C7BD3Q40054428-CE5E4288-E315-45F0-B330-FFB483A457AEQ40921326-D276AB20-AE15-4E85-926F-64D52BD74FF5Q42532569-05D89071-100A-488D-8114-73C304873513Q48377309-8756FBD8-34C2-402B-BCE3-F558D38D12B2Q49598911-DDA3909C-4711-460D-AAF3-B7CF8FC0D441Q55262651-45E2D70E-1420-4A69-8271-11A770DA5DE0Q55310119-6187948F-38F2-4F46-8B4E-7161D581E94DQ55494290-5B4D464A-70BD-402C-9B66-3502F922531F
P2860
Characterisation and differential expression of two very closely related G-protein-coupled receptors, GPR139 and GPR142, in mouse tissue and during mouse development
description
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Dezember 2005 veröffentlicher wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/03/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/03/01)
@nl
наукова стаття, опублікована в березні 2006
@uk
مقالة علمية (نشرت في مارس 2006)
@ar
name
Characterisation and different ...... e and during mouse development
@ast
Characterisation and different ...... e and during mouse development
@en
Characterisation and different ...... e and during mouse development
@nl
type
label
Characterisation and different ...... e and during mouse development
@ast
Characterisation and different ...... e and during mouse development
@en
Characterisation and different ...... e and during mouse development
@nl
prefLabel
Characterisation and different ...... e and during mouse development
@ast
Characterisation and different ...... e and during mouse development
@en
Characterisation and different ...... e and during mouse development
@nl
P2093
P921
P3181
P1433
P1476
Characterisation and different ...... e and during mouse development
@en
P2093
H Chica Schaller
Irm Hermans-Borgmeyer
Ute Süsens
P304
P3181
P356
10.1016/J.NEUROPHARM.2005.11.003
P50
P577
2005-12-27T00:00:00Z